Cargando…

The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death

Hepatocellular carcinoma (HCC) is the third main cause of cancer-related death. Cyclin-dependent kinases (CDKs) and their cyclin partners regulate the cell cycle. Since inhibition of CDKs gives some guiding ideas for cancer studies, we aimed to determine the possible effects of R547, a cyclin kinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	HACIOĞLU*, Betül, KUŞ, Gökhan, KUTLU, Hatice Mehtap, KABADERE, Selda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049457/ https://www.ncbi.nlm.nih.gov/pubmed/32123493 http://dx.doi.org/10.3906/biy-1907-3

Ejemplares similares

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Inhibitors of Cyclin-Dependent Kinases: Types and Their Mechanism of Action
por: Łukasik, Paweł, et al.
Publicado: (2021)

THU547 Role Of NAD(+) Synthesis Pathway In PARP Inhibitor Resistance
por: Myong, Subin, et al.
Publicado: (2023)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

Activation of Cyclin-Dependent Kinase 5 Is a Consequence of Cell Death
por: Ye, Yixia, et al.
Publicado: (2009)

Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy: Miniperspective
por: Sonawane, Yogesh A., et al.
Publicado: (2016)

Cyclin-Dependent Kinase Inhibitors Induce Apoptosis in Plant Cells
por: Strnad, M., et al.
Publicado: (2001)

Purine Inhibitors of Cyclin-Dependent Kinase and Their Apoptosis and Cytotoxicity Mechanisms
por: Strnad, M., et al.
Publicado: (2001)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

Potent Activity of Composite Cyclin Dependent Kinase Inhibition against Hepatocellular Carcinoma
por: Shao, Yu-Yun, et al.
Publicado: (2019)

Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

547. Molnupiravir and Nirmatrelvir/Ritonavir Effectiveness in Reducing the Risk for COVID-19 Disease Progression and Death
por: Paraskevis, Dimitrios, et al.
Publicado: (2023)

Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents
por: Park, David S., et al.
Publicado: (1998)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Cip/Kip cyclin-dependent protein kinase inhibitors and the road to polyploidy
por: Ullah, Zakir, et al.
Publicado: (2009)

Efficient Activation of Reconstructed Rat Embryos by Cyclin-Dependent Kinase Inhibitors
por: Webb, Robin L., et al.
Publicado: (2010)

Optimization of Luminescent Assay for Screening of Cyclin-Dependent Kinase 2 Inhibitors
por: Suthar, M. P., et al.
Publicado: (2010)

Pharmacokinetics and biodistribution of the cyclin-dependent kinase inhibitor -CR8- in mice
por: Sallam, Hatem, et al.
Publicado: (2013)

The inhibitors of cyclin-dependent kinases and GSK-3β enhance osteoclastogenesis
por: Akiba, Yosuke, et al.
Publicado: (2015)

Are all cyclin-dependent kinases 4/6 inhibitors created equal?
por: Marra, Antonio, et al.
Publicado: (2019)

The efficacy of the cyclin-dependent kinase 4/6 inhibitor in endometrial cancer
por: Tanaka, Tomohito, et al.
Publicado: (2017)

Cyclin-dependent kinase 7 inhibitor THZ1 in cancer therapy
por: Li, Bin-Bin, et al.
Publicado: (2019)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
por: Alsfouk, Aisha
Publicado: (2021)

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
por: Thoma, Oana-Maria, et al.
Publicado: (2021)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

547 Neonatal outcomes of COVID-19 positive mothers
por: Zarudskaya, Oxana, et al.
Publicado: (2021)

547 Clinical Outcomes for Burned Patients with Covid-19
por: Walters, Elliot, et al.
Publicado: (2022)

Identification of novel inhibitors against Cyclin Dependent Kinase 9/Cyclin T1 complex as: Anti cancer agent
por: Hussain, Afzal, et al.
Publicado: (2017)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers
por: Hur, Saem, et al.
Publicado: (2020)

Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma
por: Xu, Chenzhou, et al.
Publicado: (2018)

Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma
por: Wei, Zhong-liu, et al.
Publicado: (2022)

Frequent Loss of the Cyclin‐dependent Kinase‐4 Inhibitor Gene in Human Gliomas
por: Gomi, Akira, et al.
Publicado: (1995)

Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs
por: Cartwright, Jennifer A., et al.
Publicado: (2019)

Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02
por: von Achenbach, Caroline, et al.
Publicado: (2020)

Cyclin-dependent kinase inhibitors in brain cancer: current state and future directions
por: Juric, Viktorija, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_udglq5qju9q8vr3fch704k95u7